Market Overview:
On the basis of type, the market is segmented into single injection, three injection, five injection, and others. On the basis of application, the market is segmented into hospitals, clinics,, and others.
Product Definition:
This treatment is used to help relieve the symptoms of arthritis, such as pain and inflammation.
Single Injection:
The single injection can last for a longer period of time and has shown promising results in comparison with traditional methods such as the multiple injections.
The global SI treatment for arthritis market is expected to witness lucrative growth over the forecast period owing to factors such as rising geriatric population, increasing awareness about new treatment procedures,.
Three Injection:
The three injections are given at different sites in the body depending upon which joint is affected by arthritis. This treatment helps in reducing pain and inflammation associated with osteoarthritis, rheumatoid arthritis or gouty arthritis.
Application Insights:
Moreover, hospitals have an experienced team of healthcare professionals who can treat various joint diseases efficiently. In addition, these treatments are expensive at hotels and clinics as they do not have the required equipment or facilities to perform them; therefore, patients preferring this mode of treatment should seek medical advice from their doctors before opting for it.
The others segment includes surgical centers and other health care providers such as optometrists and osteopaths who perform these injections therapeutically without any surgical intervention or instrumentality required.
Regional Analysis:
North America dominated the global market in 2017 owing to the presence of a large number of patients suffering from osteoarthritis and growing awareness about advanced medical treatments. In addition, availability of skilled professionals and improvement in healthcare infrastructure is expected to drive regional growth over the forecast period.
Asia Pacific is anticipated to witness lucrative growth during the forecast period due to rising disposable income, increasing population, improving healthcare facilities & services along with government initiatives for improving public health system & infrastructure. Moreover, an increase in sports activities has led to an increase in demand for joint-injectable products such as hyaluronic acid (HA) which will further boost regional product sales over the next eight years.
The key players operating in this industry are Zimmer Biomet; Stryker; DePuy Synthes; Johnson & Johnson Services Inc.
Growth Factors:
- Increasing prevalence of arthritis: The global prevalence of arthritis is expected to increase from 9.4% in 2010 to 14.5% by 2030, owing to the aging population and rising obesity rates. This will create a large pool of patients who could benefit from viscosupplementation treatment for arthritis, thereby driving market growth.
- Growing awareness about viscosupplementation treatment: There is growing awareness among both physicians and patients about the benefits of viscosupplementation treatment for arthritis, which is likely to drive market growth in the coming years.
- Availability of new products: A number of new products are being launched in the viscosupplementation treatment for arthritis market, offering more choices to physicians and patients alike. This will help boost market growth over the forecast period.
Scope Of The Report
Report Attributes
Report Details
Report Title
Viscosupplementation Treatment for Arthritis Market Research Report
By Type
Single Injection, Three Injection, Five Injection,
By Application
Hospitals, Clinics, Others,
By Companies
Sanofi, Anika Therapeutics, Seikagaku, Zimmer, Bioventus, Ferring, Lifecore Biomedical, LG Life Sciences
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
241
Number of Tables & Figures
169
Customization Available
Yes, the report can be customized as per your need.
Global Viscosupplementation Treatment for Arthritis Market Report Segments:
The global Viscosupplementation Treatment for Arthritis market is segmented on the basis of:
Types
Single Injection, Three Injection, Five Injection,
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Clinics, Others,
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Sanofi
- Anika Therapeutics
- Seikagaku
- Zimmer
- Bioventus
- Ferring
- Lifecore Biomedical
- LG Life Sciences
Highlights of The Viscosupplementation Treatment for Arthritis Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Single Injection
- Three Injection
- Five Injection
- By Application:
- Hospitals
- Clinics
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Viscosupplementation Treatment for Arthritis Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Viscosupplementation is a treatment for arthritis that involves the use of viscosupplements, which are substances that help to increase the flow of blood and lymph. This can improve the symptoms of arthritis, including pain, inflammation, and stiffness. Viscosupplementation may also help to reduce the risk of joint damage or disability.
Some of the key players operating in the viscosupplementation treatment for arthritis market are Sanofi, Anika Therapeutics, Seikagaku, Zimmer, Bioventus, Ferring, Lifecore Biomedical, LG Life Sciences.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Viscosupplementation Treatment for Arthritis Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Viscosupplementation Treatment for Arthritis Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Viscosupplementation Treatment for Arthritis Market - Supply Chain
4.5. Global Viscosupplementation Treatment for Arthritis Market Forecast
4.5.1. Viscosupplementation Treatment for Arthritis Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Viscosupplementation Treatment for Arthritis Market Size (000 Units) and Y-o-Y Growth
4.5.3. Viscosupplementation Treatment for Arthritis Market Absolute $ Opportunity
5. Global Viscosupplementation Treatment for Arthritis Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Viscosupplementation Treatment for Arthritis Market Size and Volume Forecast by Type
5.3.1. Single Injection
5.3.2. Three Injection
5.3.3. Five Injection
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Viscosupplementation Treatment for Arthritis Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Viscosupplementation Treatment for Arthritis Market Size and Volume Forecast by Application
6.3.1. Hospitals
6.3.2. Clinics
6.3.3. Others
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Viscosupplementation Treatment for Arthritis Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Viscosupplementation Treatment for Arthritis Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Viscosupplementation Treatment for Arthritis Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Viscosupplementation Treatment for Arthritis Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Viscosupplementation Treatment for Arthritis Demand Share Forecast, 2019-2026
9. North America Viscosupplementation Treatment for Arthritis Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Viscosupplementation Treatment for Arthritis Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Viscosupplementation Treatment for Arthritis Market Size and Volume Forecast by Application
9.4.1. Hospitals
9.4.2. Clinics
9.4.3. Others
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Viscosupplementation Treatment for Arthritis Market Size and Volume Forecast by Type
9.7.1. Single Injection
9.7.2. Three Injection
9.7.3. Five Injection
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Viscosupplementation Treatment for Arthritis Demand Share Forecast, 2019-2026
10. Latin America Viscosupplementation Treatment for Arthritis Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Viscosupplementation Treatment for Arthritis Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Viscosupplementation Treatment for Arthritis Market Size and Volume Forecast by Application
10.4.1. Hospitals
10.4.2. Clinics
10.4.3. Others
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Viscosupplementation Treatment for Arthritis Market Size and Volume Forecast by Type
10.7.1. Single Injection
10.7.2. Three Injection
10.7.3. Five Injection
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Viscosupplementation Treatment for Arthritis Demand Share Forecast, 2019-2026
11. Europe Viscosupplementation Treatment for Arthritis Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Viscosupplementation Treatment for Arthritis Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Viscosupplementation Treatment for Arthritis Market Size and Volume Forecast by Application
11.4.1. Hospitals
11.4.2. Clinics
11.4.3. Others
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Viscosupplementation Treatment for Arthritis Market Size and Volume Forecast by Type
11.7.1. Single Injection
11.7.2. Three Injection
11.7.3. Five Injection
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Viscosupplementation Treatment for Arthritis Demand Share, 2019-2026
12. Asia Pacific Viscosupplementation Treatment for Arthritis Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Viscosupplementation Treatment for Arthritis Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Viscosupplementation Treatment for Arthritis Market Size and Volume Forecast by Application
12.4.1. Hospitals
12.4.2. Clinics
12.4.3. Others
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Viscosupplementation Treatment for Arthritis Market Size and Volume Forecast by Type
12.7.1. Single Injection
12.7.2. Three Injection
12.7.3. Five Injection
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Viscosupplementation Treatment for Arthritis Demand Share, 2019-2026
13. Middle East & Africa Viscosupplementation Treatment for Arthritis Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Viscosupplementation Treatment for Arthritis Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Viscosupplementation Treatment for Arthritis Market Size and Volume Forecast by Application
13.4.1. Hospitals
13.4.2. Clinics
13.4.3. Others
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Viscosupplementation Treatment for Arthritis Market Size and Volume Forecast by Type
13.7.1. Single Injection
13.7.2. Three Injection
13.7.3. Five Injection
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Viscosupplementation Treatment for Arthritis Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Viscosupplementation Treatment for Arthritis Market: Market Share Analysis
14.2. Viscosupplementation Treatment for Arthritis Distributors and Customers
14.3. Viscosupplementation Treatment for Arthritis Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Sanofi
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Anika Therapeutics
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Seikagaku
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Zimmer
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Bioventus
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Ferring
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Lifecore Biomedical
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. LG Life Sciences
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. COMPANY9
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
